Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 02/20/2026 | CALL | $12.00 | 1,096 | +100 | +10.04% |
| 06/18/2026 | PUT | $8.00 | 99 | +30 | +43.48% |
| 02/20/2026 | CALL | $11.00 | 777 | +10 | +1.30% |
| 02/20/2026 | CALL | $10.00 | 334 | +5 | +1.52% |
| 01/21/2028 | CALL | $30.00 | 87 | +5 | +6.10% |
| 01/21/2028 | CALL | $8.00 | 40 | +3 | +8.11% |
| 03/20/2026 | CALL | $16.00 | 32 | -2 | -5.88% |
| 03/20/2026 | CALL | $25.00 | 74 | -2 | -2.63% |
| 01/15/2027 | CALL | $15.00 | 276 | -3 | -1.08% |
| 02/20/2026 | PUT | $12.00 | 44 | -6 | -12.00% |
| 03/20/2026 | CALL | $8.00 | 76 | -7 | -8.43% |
| 06/18/2026 | CALL | $11.00 | 28 | -8 | -22.22% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| ARK ETF Tr-ARK Innovation ETF | 6.79% | 106.64M | 230.35M |
| ARK ETF Tr-ARK Genomic Revolution ETF | 2.97% | 46.62M | 100.7M |
| Vanguard Total Stock Market Index Fund | 2.25% | 35.3M | 76.26M |
| Vanguard Small-Cap Index Fund | 1.89% | 29.67M | 64.08M |
| Vanguard U.S. Growth Fund | 1.19% | 18.63M | 40.25M |
| Vanguard Small-Cap Growth Index Fund | 1.09% | 17.16M | 37.08M |
| Vanguard Extended Market Index Fund | 0.78% | 12.19M | 26.34M |
| Morgan Stanley Inst Fd Inc-Growth Port | 0.74% | 11.54M | 24.93M |
| iShares NASDAQ Biotechnology ETF | 0.48% | 7.53M | 16.27M |
| Fidelity Extended Market Index Fund | 0.29% | 4.56M | 9.85M |
A-Alpha Bio Appoints Troy Lionberger as New Chief Business Officer to Drive Next Phase of Growth
09/23 12:00 pm
GlobeNewswire Inc.
Read moreGlobal Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight
03/03 02:00 pm
GlobeNewswire Inc.
Read moreSynthetic Biology Market Forecast: $61.6 Billion by 2029, Growing at 26.1% CAGR
12/05 01:53 pm
GlobeNewswire Inc.
Read moreTransforming Healthcare From The Inside Out, Nanorobots Are Revolutionizing Treatment With Precision At The Nanoscale: A Report by TNR, The Niche Research
10/08 09:00 am
GlobeNewswire Inc.
Read moreNanobots in Healthcare Research Report 2024: A $7.1 Billion Market in 2023 - Global Forecast to 2030 - Revolutionizing Healthcare with Targeted Drug Delivery and Minimally Invasive Surgeries
10/02 06:48 am
GlobeNewswire Inc.
Read morePomerantz LLP Announces that this is a Reminder of a Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNA
09/18 09:00 am
GlobeNewswire Inc.
Read moreWhy Ginkgo Bioworks Holdings Stock Raced 9% Higher Today
09/17 06:07 pm
The Motley Fool
Read moreGoogle Cloud Expands Its Partnership With Ginkgo Bioworks For Two New AI-Tools Faster Drug Development
09/17 01:48 pm
Benzinga
Read moreDown a Monstrous 90% This Year, Is There Any Hope Left for Ginkgo Bioworks Investors?
09/05 07:50 am
The Motley Fool
Read morePomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Ginkgo Bioworks Holdings, Inc. Common Stock - DNA
09/04 09:00 am
GlobeNewswire Inc.
Read more2 Big Risks and 2 Big Opportunities for Ginkgo Bioworks Stock
09/03 08:45 am
The Motley Fool
Read moreThis 1 AI Stock Could Revolutionize Biotech and Pharma
09/02 05:11 am
The Motley Fool
Read moreDown 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?
08/24 10:11 am
The Motley Fool
Read moreDown 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?
08/15 05:27 am
The Motley Fool
Read morePrediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks
08/13 07:05 am
The Motley Fool
Read moreSynthetic Biology market is projected to grow at a CAGR of 25.4% by 2034: Visiongain - GlobeNewswire
07/19 07:11 am
GlobeNewswire Inc.
Read moreDown 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy? - The Motley Fool
07/14 08:05 am
The Motley Fool
Read moreGinkgo Bioworks executive sells over $4k in stock to cover taxes By Investing.com - Investing.com
07/05 04:11 pm
Investing.com
Read moreWhy Ginkgo Bioworks Stock Is Sinking Today
06/26 11:19 am
The Motley Fool
Read moreBull Market and Beyond: 3 Stocks Just Waiting to Soar
06/11 05:10 am
The Motley Fool
Read moreAfter Plunging -40.22% in 4 Weeks, Here's Why the Trend Might Reverse for Ginkgo Bioworks (DNA)
06/07 09:35 am
Zacks Investment Research
Read moreGinkgo Bioworks Stock: Bull vs. Bear
05/31 05:47 am
The Motley Fool
Read moreShould You Buy the Dip on Ginkgo Bioworks Stock?
05/30 06:30 am
The Motley Fool
Read more2 Cathie Wood Biotech Stocks That Could Be Worth the Risk
05/29 06:00 am
The Motley Fool
Read moreCathie Wood's Ark Innovation ETF Sees Sharp Decline Among Top Holdings — Here Are 10-Largest Losers Within ARKF
05/28 07:29 am
Benzinga
Read more3 Things You Need to Know if You Buy Ginkgo Bioworks Today
05/25 08:30 am
The Motley Fool
Read moreDown 72%. Is Ginkgo Bioworks a Buy on the Dip?
05/25 04:57 am
The Motley Fool
Read moreGinkgo Bioworks Stock Has 37.5% Downside, According to 1 Wall Street Analyst
05/20 12:40 pm
The Motley Fool
Read moreInvestment Advisor Says 'Throwing Random Darts At Tickers' Would Beat ARKK As Cathie Wood's Flagship Fund Lags Far Behind Soaring Market: 'How Do They Do It?!'
05/20 06:51 am
Benzinga
Read moreIs Ginkgo Bioworks Holdings Stock a Buy?
05/18 02:38 pm
The Motley Fool
Read more4 Small-Cap Value Stocks That Could Go Parabolic
05/16 09:30 am
The Motley Fool
Read moreWhat's the Difference Between Biotech Stocks and TechBio Stocks?
05/15 08:45 am
The Motley Fool
Read moreGinkgo's Q1 Earnings Were a Mixed Bag
05/10 11:31 am
The Motley Fool
Read moreGinkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Lags Revenue Estimates
05/09 05:45 pm
Zacks Investment Research
Read moreGinkgo Bioworks Stock Falls On Disappointing Q1 Sales: 'This Trend Needs To Change'
05/09 04:49 pm
Benzinga
Read moreGinkgo Bioworks: Buy, Sell, or Hold?
04/30 10:00 am
The Motley Fool
Read moreUse These Penny Stocks Trading Psychology Tips
04/29 06:41 am
PennyStocks
Read moreAre Penny Stocks Worth the Risk?
04/27 05:26 am
PennyStocks
Read moreTracking Cathie Wood's ARK Invest 13F Portfolio - Q1 2024 Update
04/19 03:54 am
Seeking Alpha
Read moreNovo Nordisk and Ginkgo Bioworks Are Teaming Up. Here's Why That's Bullish for Both Stocks.
04/15 10:00 am
The Motley Fool
Read moreBull Market and Beyond: 3 Stocks Just Waiting to Soar
04/09 04:50 am
The Motley Fool
Read moreThe AI Advantage: 2 Healthcare Stocks at the Forefront of Innovation
04/08 09:00 am
The Motley Fool
Read more2 Stocks That Could More Than Double Your Money, According to Wall Street: Are They Buys Now?
04/03 04:19 am
The Motley Fool
Read moreSizing Your Penny Stocks Position, 3 Tips
03/31 06:26 am
PennyStocks
Read moreIs Ginkgo Bioworks Stock a Buy?
03/15 05:07 pm
The Motley Fool
Read more3 Pharmaceutical Stocks to Buy Hand Over Fist in March
03/11 09:28 am
The Motley Fool
Read moreIs Ginkgo Bioworks Destined to Be in a "Magnificent Seven" of Healthcare Stocks?
03/03 01:45 pm
The Motley Fool
Read more